Preethi Sundaram Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity
Preethi Sundaram is Chief Strategy Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 25,541 shares of CPRX, which is worth approximately $559,092. The most recent transaction as insider was on Feb 15, 2024, when has been sold 6,025 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
25.5K
0%
3M change
140.0%
12M change
Total Value Held
$559,092
Preethi Sundaram Transaction History
PS
Preethi Sundaram
Chief Strategy Officer
Coral Gables, FL